<?xml version='1.0' encoding='utf-8'?>
<document id="23851929"><sentence text="Effects of a three party healthcare network on the incidence levels of drug related problems." /><sentence text="Drug related problems (DRPs) are impairing patients' health and cause high costs" /><sentence text=" Neither delegation of home medication review nor regular pharmaceutical care are common in Germany" /><sentence text="" /><sentence text="We aimed to reduce several DRP by the implementation of a three party healthcare team [AGnES-practice assistant, pharmacist, general practitioner (GP)] and adherence supporting strategies (using a medication reminder chart, medication compliance aid)" /><sentence text="" /><sentence text="The setting was ambulatory primary healthcare in German rural areas with a cohort of home-dwelling, elderly, mostly multimorbid patients with limited mobility (study period: 06/2006-12/2008)" /><sentence text="" /><sentence text="We conducted a prospective non-randomized implementation cohort study with home medication review (home medication review module; mean participation time: 9 months)" /><sentence text=" Data collection was delegated to additionally qualified AGnES-practice assistants (AGnES: GP-supporting, community-based, e-health-assisted systemic intervention)" /><sentence text=" The intervention comprised pharmaceutical care by the local pharmacy in addition to medical interventions by the GP" /><sentence text=" 408 patients (mean age: women: 80" /><sentence text="7 years; men: 75" /><sentence text="3 years) received both pharmaceutical care and at least one follow-up visit" /><sentence text="" /><sentence text="Outcome measurements comprised self-reported DRPs, objectively evaluated DRP, and prevalence of adherence supporting strategies" /><sentence text="" /><sentence text="The three party healthcare team approach reduced self-reported forgetfulness (7" /><sentence text="7-3" /><sentence text="2 %; p = 0" /><sentence text="001), the proportion of patients with intermittent drug intake (5" /><sentence text="3-1" /><sentence text="3 %; p &lt; 0" /><sentence text="001), and the proportion of patients with potentially clinical relevant drug-drug interaction (61" /><sentence text="6-51" /><sentence text="2 %; p &lt; 0" /><sentence text="001)" /><sentence text=" Self-reported adverse drug reactions decreased non-significantly (5" /><sentence text="4-4" /><sentence text="6 %; p = 0" /><sentence text="564; all tests χ²-McNemar)" /><sentence text=" The median number of active substances taken was reduced from 8 to 7 (p &lt; 0" /><sentence text="001; Wilcoxon signed rank test)" /><sentence text=" The proportions of patients using medication charts and compliance aids increased significantly (75" /><sentence text="2-90" /><sentence text="3 %; p &lt; 0" /><sentence text="001) and (70" /><sentence text="0-80" /><sentence text="1 %; p &gt; 0" /><sentence text="001), respectively" /><sentence text="" /><sentence text="This is the first study evaluating effects of a three party team on DRPs in a primary healthcare setting in Germany" /><sentence text=" This approach led to reduction in the occurrence of several DRPs and improved adherence supporting strategies" /><sentence text=" However, the study is a pre-post analysis, and had no control group" /><sentence text="" /></document>